Biostimulatory treatments depend on the patient’s own fibroblast activity. Where nutritional status is limiting, the protocol is working against a supply constraint the practitioner cannot see in the treatment room.
Introducing a daily oral protocol before a treatment course gives a consistent baseline, improves the conversation about realistic timelines, and creates a natural retail touchpoint that does not feel like an upsell.
In practice, clinics that succeed with this position the supplement as part of the plan at consultation rather than at the till, use one clear product story rather than a shelf of options, and set review points that match the treatment schedule.
None of this replaces clinical judgement, and no supplement should be presented as changing the indication or outcome of a medical procedure.